Anthera Pharmaceuticals
We are focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs.
Find out more about what we are doing for patients with Cystic Fibrosis and IgA Nephropathy:
Anthera Pharmaceuticals Announces RESULT Phase 3 Clinical Study of Sollpura will be Included in the Cystic Fibrosis Foundation Therapeutics Development Network. Read more
Anthera Pharmaceuticals Announces Expansion of Screening in European Sites in Phase 3 RESULT Clinical Study of Sollpura. Read more
